The researchers found that the drug, sold under brand name Singulair and generically as montelukast, attaches to multiple brain receptors critical to psychiatric functioning. Published first on TheFly ...
10-day median time to symptom resolution Time to sustained recovery, defined as three or more days without symptoms, didn't differ between the 628 and 622 participants assigned to montelukast or ...
The clinical efficacy of montelukast has been assessed in adults and children with persistent asthma, typically those with forced expiratory volume in 1 second (FEV 1) of 50 to 85% of predicted.
A widely used asthma therapy first marketed by Merck (NYSE:MRK) may be associated with severe mental issues, including suicidal thoughts, for some patients, Reuters reported Friday, citing a ...
Montelukast is a cysteinyl leukotriene receptor antagonist indicated for the management of persistent asthma in those aged ≥ years. Although it improves pulmonary function and symptoms ...
The researchers found that the drug, sold under brand name Singulair and generically as montelukast, attaches to multiple brain receptors critical to psychiatric functioning. Don't Miss our Black ...
OAKLAND, Calif. — Merck & Co., the pharmacology giant that manufactures the anti-inflammatory treatment montelukast aka Singulair, defeated product liability claims in a California federal court.
This leaflet answers some common questions about Montelukast Viatris. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast Sodium immediate release tablets in the strength of 10mg and Montelukast Sodium chewable tablets in 4mg ...